Korro Bio Inc
(KRRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,686 | -63,186 | -38,031 | -20,375 | -26,511 |
| Depreciation Amortization | 2,775 | 2,038 | 1,303 | 382 | 1,146 |
| Accounts payable and accrued liabilities | -2,292 | -1,910 | -2,355 | -1,846 | 4,287 |
| Other Working Capital | -17,327 | -14,299 | -17,573 | -10,378 | -30,240 |
| Other Operating Activity | 25,471 | 19,186 | 13,508 | 6,743 | 6,130 |
| Operating Cash Flow | $-76,059 | $-58,171 | $-43,148 | $-25,474 | $-45,188 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,914 | -2,853 | -2,542 | -543 | -6,671 |
| Purchase Of Investment | -92,445 | -66,226 | -43,023 | -25,666 | -26,345 |
| Sale Of Investment | 29,233 | 17,600 | 2,500 | N/A | 43,418 |
| Investing Cash Flow | $-66,126 | $-51,479 | $-43,065 | $-26,209 | $10,402 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 15,000 |
| Common Stock Issued | 1,358 | 1,249 | 900 | 572 | 1,545 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 40,143 |
| Financing Cash Flow | $1,358 | $1,249 | $900 | $572 | $56,688 |
| Beginning Cash Position | 222,161 | 222,161 | 222,161 | 222,161 | 200,259 |
| End Cash Position | 81,334 | 113,760 | 136,848 | 171,050 | 222,161 |
| Net Cash Flow | $-140,827 | $-108,401 | $-85,313 | $-51,111 | $21,902 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,059 | -58,171 | -43,148 | -25,474 | -45,188 |
| Capital Expenditure | -2,914 | -2,853 | -2,542 | -543 | -6,671 |
| Free Cash Flow | -78,973 | -61,024 | -45,690 | -26,017 | -51,859 |